FDA Inspection 1056187 — Daniel J Finn, MD
The FDA completed an inspection of Daniel J Finn, MD on Jun 11, 2018 in Bardstown, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 11, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Bardstown, KY (United States)
Additional Details
Clinical Investigator (CI)